APPLIED STEMCELL, INC.

Applied StemCell (ASC) is a genome engineering platform company advancing the future of genetic and cell-based medicine through its proprietary TARGATT™ technology, which enables safe, scalable, site-specific integration of large DNA payloads into the mammalian genome. With deep expertise in induced pluripotent stem cells (iPSCs) and cell line engineering, ASC provides end-to-end CRO/CDMO solutions that accelerate innovation across academia and biopharma. The company's strong IP foundation and cutting-edge technologies empower partners to move from concept to clinic with precision, scalability, and confidence.